experts comment on an observational study on GLP-1 receptor agonists and lower risk of worsening mental illness Prof … read more
A cohort study published in The BMJ looks at GLP-1 use and the risk of substance use among US veterans with type … read more
A meta-analysis published in eClinicalMedicine looks at weight regain trajectories after stopping GLP-1 receptor agonist medication. Dr Adam Collins, Associate … read more
A study in rodent cells published in Nature Communications looks at GLP-1 peptides and heart vessel damage. Prof Bryan Williams, … read more
Trial results published in The Lancet looks at the efficacy and safety of a once daily-daily oral pill (Orforglipron) compared to semaglutide. … read more
What happens to body weight and measures of cardiometabolic health after people stop taking obesity drugs? A new systematic review … read more
A systematic review and meta-analysis published in the BMJ looks at weight regain after stopping obesity drugs. Prof Jason … read more
Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
Scientists respond to article published in Nature Medicine exploring the link between weight-loss drugs and food cravings. Dr Simon Cork, Senior … read more
A study published in the Lancet looks at semaglutide and cardiovascular health regardless of weight loss. Dr Sonya Babu-Narayan, Clinical Director, … read more
An unpublished conference abstract presented at the European Association for the Study of Diabetes (EASD) looks at a new RNA-based weight … read more
A study published in JAMA Pediatrics looks at the safety of weight loss drugs in children and adolescents with obesity or type … read more
Two studies published in The Lancet Diabetes & Endocrinology looks at the effect of higher doses of semaglutide on weight loss … read more
An observational study published in JAMA Oncology looks at GLP-1 receptor agonists and cancer risk in adults with obesity. Prof Paul … read more
Scientists comment on oral GLP-1 (Orforglipron) and weight loss from a phase 3 clinical trial. Dr Simon Cork, Senior … read more
A study published in Cell Metabolism looks at the effects of semaglutide on skeletal muscle mass in mice. Prof Lora Heisler, … read more
An observational study published in BMJ Open Diabetes Research & Care looks at GLP-1 drugs vs metformin and the risk of … read more
A study published in JAMA Network Open looks at the association between people with obesity and diabetes taking weight loss drugs, … read more